Patents expiring in 2029

US 7622272

Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622130

Methods and compositions for the non-surgical removal of fat

The Regents of the University of California · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622447

Use of glutathione synthesis stimulating compounds in reducing insulin resistance

DiaMedica Inc. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622461

Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

ACADIA Pharmaceuticals Inc. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622463

Dihydrodiazepines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622549

Human telomerase reverse transcriptase polypeptides

The Regents of the University of Colorado · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622480

Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents

Laboratories Almirall, S.A. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622508

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622556

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622587

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622588

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622610

Crystalline ACAT inhibitor

Graceway Pharmaceuticals. LLC · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622571

Methods and compositions for Mycoplasma pneumoniae exotoxins

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622107

Recombinant intracellular pathogen immunogenic compositions and methods for use

The Regents of the University of California · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622479

Bicyclic derivative, its production and use

Takeda Pharmaceutical Company Limited · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622444

Methods for using OX-40 ligand to enhance an antigen specific immune response

Sisters of Providence in Oregon · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622118

Cancer treatment methods using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7622105

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7621740

Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

Prime Pharmaceutical Corporation · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625871

Indole antiviral compositions and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7626042

O-substituted hydroxyaryl derivatives

Institute of Medicinal Molecular Design, Inc. · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625869

Metastin derivatives and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625563

Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625887

Receptor agonists

Takeda Pharmaceutical Company Limited · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625696

Screening method

Takeda Pharmaceutical Company Limited · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625736

Methods for preparing immunogenic conjugates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625571

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625575

Dermatological composition

Harmony Labs, Inc. · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7625913

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7626014

Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7627938

Tapered hollow metallic microneedle array assembly and method of making and using the same

The Board of Regents of the University of Texas System · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7629380

Antitumor agents

The Regents of the University of California · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7629323

Manipulation of neuronal ion channels

Northwestern University · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7629458

Preparation of levofloxacin and hemihydrate thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7629336

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7629383

Double esters

DRUG DISCOVERY LABORATORY AS · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7629168

Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof

Kuraray Medical Inc. · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7629308

Methods relating to muscle selective calcineurin interacting protein (MCIP)

The Board of Regents of the University of Texas System · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7629005

Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

Bionorica AG · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632847

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632841

2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632814

HYD1 peptides as anti-cancer agents

The Regents of the University of California · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632510

Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632659

Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632508

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

The United States of America · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632503

Method of treating a muscle-related condition with modified IGF1 polypeptides

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632490

Use of IL-1 antagonists to treat gout

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632484

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

The Board of Regents of the University of Texas System · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)